TY - JOUR
T1 - Robustness of the signal transduction system of the mammalian JAK/STAT pathway and dimerization steps
AU - Shudo, Emi
AU - Yang, Jin
AU - Yoshimura, Akihiko
AU - Iwasa, Yoh
N1 - Funding Information:
This work was supported by Grants-in-Aid from JSPS to E.S. and to Y.I. Additionally, portions of this work were done under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396 and supported by NIH grants AI28433, RR06555 and P20-RR18754. We thank the following people for their helpful comments: Dr. M. Bilnov, Dr. J.S. Cavenaugh, Dr. J.R. Faeder, Ms. L. Fortgang, Dr. B. Goldstein, Dr. K. Harada, Dr. W.S. Hlavacek, Dr. T. Kajiwara, Dr. H. Katsuragi, Dr. D. Krakauer, Dr. J. Nakabayashi, Dr. Y. Morishita, Dr. M. Mustyakimov, Dr. A.S. Perelson, Dr. A. Sasaki, Dr. T. Sasaki, Dr. H. Shoji, Dr. T. Ueno and Dr. S. Yamada.
PY - 2007/5/7
Y1 - 2007/5/7
N2 - In the interferon-γ (IFNγ)-activated Janus Kinase (JAK)/signal transducer and activator of transcription 1 (STAT1) pathway, multiple steps of STAT1 dimerization are required prior to gene expression that produce antiviral molecules. By interpreting experimental results, an existing mathematical model suggested that only phosphorylated STAT1 dimers could translocate to the nucleus and activate gene transcription. In this paper, we examine the role of STAT1 dimerization steps by studying the dynamic behaviors of four alternative models. By analyzing several system properties at low input IFNγ signal including the steady-state antiviral molecule production, to the input, the delay of responses triggered by input, and the parameter sensitivity, we found that the mice JAK/STAT1 system identified by experiments (1) suppresses antiviral molecule production at low input signal, (2) has slow kinetics of antiviral molecule production and (3) has low parameter sensitivity of antiviral molecule production at steady state. We conclude that the observed structure of the JAK/STAT1 pathway is responsible for the robust system behavior.
AB - In the interferon-γ (IFNγ)-activated Janus Kinase (JAK)/signal transducer and activator of transcription 1 (STAT1) pathway, multiple steps of STAT1 dimerization are required prior to gene expression that produce antiviral molecules. By interpreting experimental results, an existing mathematical model suggested that only phosphorylated STAT1 dimers could translocate to the nucleus and activate gene transcription. In this paper, we examine the role of STAT1 dimerization steps by studying the dynamic behaviors of four alternative models. By analyzing several system properties at low input IFNγ signal including the steady-state antiviral molecule production, to the input, the delay of responses triggered by input, and the parameter sensitivity, we found that the mice JAK/STAT1 system identified by experiments (1) suppresses antiviral molecule production at low input signal, (2) has slow kinetics of antiviral molecule production and (3) has low parameter sensitivity of antiviral molecule production at steady state. We conclude that the observed structure of the JAK/STAT1 pathway is responsible for the robust system behavior.
KW - Dimerization
KW - JAK/STAT pathway
KW - Negative feedback
KW - Robust system
UR - http://www.scopus.com/inward/record.url?scp=34047269066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34047269066&partnerID=8YFLogxK
U2 - 10.1016/j.jtbi.2006.11.016
DO - 10.1016/j.jtbi.2006.11.016
M3 - Article
C2 - 17241643
AN - SCOPUS:34047269066
SN - 0022-5193
VL - 246
SP - 1
EP - 9
JO - Journal of Theoretical Biology
JF - Journal of Theoretical Biology
IS - 1
ER -